During the past decade, Mulqueeny Eye Centers conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mulqueeny Eye Centers" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mulqueeny Eye Centers" are "Dry Eye" (2 trials). Many other conditions were trialed in "Mulqueeny Eye Centers" in a lesser frequency.

Most popular intervention types in "Mulqueeny Eye Centers" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Artificial Tears" (1 trials), "Omega-3 supplements" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mulqueeny Eye Centers" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mulqueeny Eye Centers". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mulqueeny Eye Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mulqueeny Eye Centers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".